MERCURY LABORATORIES
Back to Balance Sheet
|
MERCURY LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹4.18 Cr | ₹4.36 Cr | ₹6.38 Cr | ₹9.64 Cr | ₹9.26 Cr |
What is the latest Total Non-Current Liabilities ratio of MERCURY LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹4.18 Cr |
Mar2023 | ₹4.36 Cr |
Mar2022 | ₹6.38 Cr |
Mar2021 | ₹9.64 Cr |
Mar2020 | ₹9.26 Cr |
How is Total Non-Current Liabilities of MERCURY LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.18 Cr | -4.18 | |
Mar2023 | ₹4.36 Cr | -31.69 | |
Mar2022 | ₹6.38 Cr | -33.86 | |
Mar2021 | ₹9.64 Cr | 4.18 | |
Mar2020 | ₹9.26 Cr | - |
Compare Total Non-Current Liabilities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹117.5 Cr | 4.2% | -4.1% | 19.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹434,604.0 Cr | 0.1% | -4% | 52.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,639.0 Cr | 0.7% | -0% | 70.9% | Stock Analytics | |
CIPLA | ₹128,549.0 Cr | 0.5% | -1.7% | 29.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,956.0 Cr | 1.1% | -2.6% | 19.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,468.9 Cr | -3.6% | -8.4% | 62.9% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | 4.2% |
-4.1% |
19.5% |
SENSEX | -0.3% |
-2.4% |
22.4% |
You may also like the below Video Courses